Increasing levels of artemisinin and partner drug resistance threaten malaria control and
elimination globally. Triple artemisinin-based combination therapies (TACTs) which …

Emergence of artemisinin resistance has been confirmed in Cambodia and the border areas
of Thailand, the well-known hotspots of multidrug resistance Plasmodium falciparum. It …

Antimalarial drug therapies containing artemisinins,'ACTs', have become the mainstay for
treating uncomplicated malaria in endemic countries. This is a major public health …

Background Humanity has become largely dependent on artemisinin derivatives for both the
treatment and control of malaria, with few alternatives available. A Plasmodium falciparum …

Artemisinin is an important antimalarial drug which is originated and developed from
Chinese traditional herbal regimen. At present, artemisinin is used as an antimalarial drug …

The global adoption of artemisinin-based combination therapies (ACTs) in the early 2000s
heralded a new era in effectively treating drug-resistant Plasmodium falciparum malaria …

Since 2001, 40 countries have officially adopted artemisininbased combination therapy for
treating Plasmodium falciparum malaria [1]. Of these countries, 20 have adopted the …

Introduction: Antimalarial drugs are essential weapons to fight malaria and have been used
effectively since the 17th century. However, P. falciparum resistance has been reported to …

The effectiveness of artemisinin-based combination therapies (ACTs) to treat Plasmodium
falciparum malaria is threatened by resistance. The complex interplay between sources of …

Artemisinin comes from the plant, Artemisia annua, an ancient Chinese herbal remedy for
relapsing fever. Rediscovery of its antimalarial action in China in the 1970s has seen it and …